The Ohio State University College of Medicine is the medical school at The Ohio State University and is located in Columbus, Ohio. The college is nationally recognized as a top institution in both education and research, as reflected by rankings in U.S. News & World Report.

During the past decade, The Ohio State University College of Medicine conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 7 clinical trials were completed, i.e. on average, 35% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Ohio State University College of Medicine" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Corvia Medical" with 2 trials sponsored, "Courtney D.Lynch, PhD MPH" with 2 trials sponsored and "Mirati Therapeutics Inc." with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Ohio State University College of Medicine" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "The Ohio State University College of Medicine" are "Alzheimer Disease" (2 trials), "Alzheimer's Disease" (2 trials), "Heart Failure" (2 trials), "Infertility" (2 trials) and "Pregnancy" (2 trials). Many other conditions were trialed in "The Ohio State University College of Medicine" in a lesser frequency.

Most popular intervention types in "The Ohio State University College of Medicine" are "Drug" (21 trials), "Other" (5 trials), "Device" (3 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Gantenerumab" (3 trials), "Nivolumab" (2 trials), "Sitravatinib" (2 trials) and "Abemaciclib, dexamethasone, ixazomib, pomalidomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Ohio State University College of Medicine" are 24 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Ohio State University College of Medicine". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in The Ohio State University College of Medicine, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in The Ohio State University College of Medicine, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".